Dr. Treadwell is currently focusing her primary interests on patient-oriented, biobehavioral research. She has a study underway to evaluate psychobiological reactivity as a robust predictor of sickle cell pain, defined as the rate of painful episodes and daily pain frequency and intensity, for children ages five to twelve with sickle cell disease; and to evaluate the independent and combined influences of physiological and psychological factors on outcomes for children with sickle cell disease.
Along with her interest in bioreactivity, Dr. Treadwell is also working to build on existing generic quality of life instruments to develop a sickle cell disease specific health related quality of life instrument that can be administered via paper and pencil, computer assisted and computer adaptive modes, and that can be utilized by clinicians, researchers and consumers.
Building on her previous community-based research, Dr. Treadwell continues to work toward increasing awareness of hemoglobin traits and access to sickle cell trait testing and counseling, within the context of an overall focus on improved health. The long-term goal of the current research is to improve emergency care for individuals with sickle cell disease by implementing an innovative program of provider education and support for patients and families in self-advocacy.